3-69939186-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001354604.2(MITF):c.666+5T>C variant causes a splice donor 5th base, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001354604.2 splice_donor_5th_base, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MITF | NM_000248.4 | c.345+5T>C | splice_donor_5th_base_variant, intron_variant | ENST00000394351.9 | NP_000239.1 | |||
MITF | NM_001354604.2 | c.666+5T>C | splice_donor_5th_base_variant, intron_variant | ENST00000352241.9 | NP_001341533.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MITF | ENST00000352241.9 | c.666+5T>C | splice_donor_5th_base_variant, intron_variant | 1 | NM_001354604.2 | ENSP00000295600 | P4 | |||
MITF | ENST00000394351.9 | c.345+5T>C | splice_donor_5th_base_variant, intron_variant | 1 | NM_000248.4 | ENSP00000377880 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250830Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135580
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460950Hom.: 0 Cov.: 31 AF XY: 0.0000482 AC XY: 35AN XY: 726842
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
Tietz syndrome;C1860339:Waardenburg syndrome type 2A;C3152204:Melanoma, cutaneous malignant, susceptibility to, 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change falls in intron 3 of the MITF gene. It does not directly change the encoded amino acid sequence of the MITF protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs374067688, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with MITF-related conditions. ClinVar contains an entry for this variant (Variation ID: 504813). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 13, 2018 | Variant classified as Uncertain Significance - Favor Benign. The c.666+5T>C vari ant in MITF has been identified by our laboratory in one individual with hearing loss and their reportedly unaffected parent. Notably, a likely alternate etiolo gy was identified in the proband. The c.666+5C>T variant has also been identifie d in 0.01% (13/128806) of European chromosomes by gnomAD (http://gnomad.broadins titute.org). This variant is located in the 5' splice region. Computational tool s do not suggest an impact to splicing, but this information is not predictive e nough to rule out pathogenicity. In summary, while the clinical significance of the c.666+5T>C variant is uncertain, available data suggest that it is more like ly to be benign. ACMG/AMP criteria applied: BP4. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 30, 2022 | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jul 11, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at